RecallHawk
Class III Recall

Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 4229

AVKARE Inc.

Summary

The FDA issued a Class III for Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: by AVKARE Inc.. Reason: Labeling: Label Error on Declared Strength.

Details

Source

Drug Recall

External ID

D-1329-2022

Action Date

2022-08-17

Status

Terminated

Category

drug

Product Description

Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4

Lot/Code Info: Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022

Quantity Affected: 8328 bottles

Reason for Recall

Labeling: Label Error on Declared Strength

Distribution

Nationwide within the United States

Type: Voluntary: Firm initiated

Recall Initiated: 2022-07-20

Company

AVKARE Inc.

Pulaski, TN

Context & Analysis

This is a Class III recall. Class III recalls involve products unlikely to cause adverse health consequences, but that violate FDA regulations.

This was one of 41 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

Frequently Asked Questions

What is a Class III recall?

A Class III recall involves products that are unlikely to cause adverse health effects but violate FDA labeling or manufacturing regulations.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (AVKARE Inc.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does AVKARE Inc. have FDA actions?

This is the only FDA action we have on record for AVKARE Inc. in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-1329-2022" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions